Palo Alto Investors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001306923

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2026 · 51 positions · Total reported value $653.86M · Top-10 concentration 63.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.8% · 4 new · 25 cut · 0 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.7% · vs SPY -4.8% · Prev Value $723.72M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.2% · vs SPY -5.3% · Latest Value $672.15M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Palo Alto Investors LP disclosed 51 equity positions with a combined reported value of $653.86M. The filing implies a focused portfolio: its ten largest positions account for 63.8% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were INSM ($67.90M), ACAD ($63.95M), PTCT ($62.79M). By sector, the heaviest allocations are Health Care 97.2%, Financials 0.3%. Versus the prior quarter, allocation shifted toward Health Care (+8.6pp) and away from Financials (-0.7pp), Other (-7.9pp).

Versus the prior quarter, Palo Alto Investors LP opened 4 new positions, trimmed 25 and fully exited 0, a turnover rate of 51.8% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q1 2026 were CLDX ($9.40M), CYTK ($2.12M), VSTM ($1.30M).

Of the 3 positions fully exited versus the prior quarter, the largest were GOSS ($13.86M), GBIO ($85.47K), AKTX ($42.20K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • CLDX CELLDEX THERAPEUTICS INC NEW · $9.40M
  • CYTK CYTOKINETICS INC · $2.12M
  • VSTM VERASTEM INC · $1.30M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $935.44K
  • XERS XERIS BIOPHARMA HOLDINGS INC · $605.58K

Fully Exited (vs previous quarter)

  • GOSS GOSSAMER BIO INC · prev qtr: $13.86M
  • GBIO GENERATION BIO CO · prev qtr: $85.47K
  • AKTX AKARI THERAPEUTICS PLC · prev qtr: $42.20K

Insider Transactions (Form 4)

Latest Palo Alto Investors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Palo Alto Investors LP, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 56 positions worth $672.15M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-58166 (status: Approved), registered 2000-12-05
  • Regulatory AUM (Form ADV): $696.00M as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds
  • Website: pa-investors.com

Portfolio Structure

  • 56 positions · $672.15M reported value (Q3 2026)
  • Top 10 holdings = 59.9% of reported value
  • Largest position: PTCT (PTC THERAPEUTICS INC) at 8.4%
  • Average position size: $12.00M

Sector Tilt

  • Health Care 99.8%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 4 new, 10 added, 25 reduced
  • 17 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 97.2%
Financials 0.3%
Other 2.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 415.27K $67.90M 10.38%
10.38%
Reduce
2 2.87M $63.95M 9.78%
9.78%
Add
3 921.61K $62.79M 9.60%
9.60%
Add
4 685.18K $38.71M 5.92%
5.92%
Reduce
5 62.81K $37.24M 5.70%
5.70%
Add
6 638.16K $35.39M 5.41%
5.41%
Reduce
7 325.18K $30.04M 4.59%
4.59%
Add
8 1.65M $29.97M 4.58%
4.58%
Add
9 140.72K $25.80M 3.94%
3.94%
Reduce
10 401.72K $25.69M 3.93%
3.93%
Add
11 6.35M $22.29M 3.41%
3.41%
Reduce
12 864.99K $20.21M 3.09%
3.09%
Add
13 2.95M $16.33M 2.50%
2.50%
Add
14 1.11M $16.09M 2.46%
2.46%
Reduce
15 1.28M $13.96M 2.13%
2.13%
Reduce
16 596.50K $12.50M 1.91%
1.91%
Add
17 1.21M $11.75M 1.80%
1.80%
Reduce
18 550.41K $10.95M 1.67%
1.67%
Add
19 296.41K $9.40M 1.44%
1.44%
New
20 531.87K $9.23M 1.41%
1.41%
Add
21 242.56K $8.58M 1.31%
1.31%
Hold
22 1.51M $8.01M 1.23%
1.23%
Reduce
23 213.60K $7.23M 1.10%
1.10%
Add
24 41.52K $7.12M 1.09%
1.09%
Hold
25 229.76K $6.98M 1.07%
1.07%
Add
26 230.45K $6.85M 1.05%
1.05%
Add
27 1.39M $6.22M 0.95%
0.95%
Add
28 1.61M $6.05M 0.93%
0.93%
Add
29 234.58K $4.50M 0.69%
0.69%
Reduce
30 51.34K $2.99M 0.46%
0.46%
Reduce
31 59.98K $2.94M 0.45%
0.45%
Hold
32 84.63K $2.76M 0.42%
0.42%
Add
33 33.64K $2.69M 0.41%
0.41%
Hold
34 18.12K $2.39M 0.36%
0.36%
Hold
35 508.85K $2.18M 0.33%
0.33%
Reduce
36 32.20K $2.12M 0.33%
0.33%
New
37 1.48M $1.91M 0.29%
0.29%
Reduce
38 39.60K $1.88M 0.29%
0.29%
Reduce
39 19.61K $1.74M 0.27%
0.27%
Hold
40 1.01M $1.48M 0.23%
0.23%
Reduce
41 246.09K $1.30M 0.20%
0.20%
New
42 201.89K $936.77K 0.14%
0.14%
Reduce
43 1.79K $935.44K 0.14%
0.14%
New
44 3.98K $690.96K 0.11%
0.11%
Hold
45 115.62K $639.36K 0.10%
0.10%
Hold
46 104.41K $605.58K 0.09%
0.09%
New
47 108.86K $487.71K 0.07%
0.07%
Hold
48 8.77K $452.46K 0.07%
0.07%
Hold
49 24.50K $440.51K 0.07%
0.07%
Hold
50 188.81K $305.87K 0.05%
0.05%
Hold

FAQ

What did Palo Alto Investors LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Palo Alto Investors LP reported 51 equity positions worth $653.86M in aggregate; its largest disclosed positions were INSM ($67.90M), ACAD ($63.95M), PTCT ($62.79M).

How large is Palo Alto Investors LP's portfolio?

Palo Alto Investors LP reported $653.86M of long equity holdings across 51 positions as of 2026-Q1. Top-10 holdings account for 63.8% of reported value.

What is Palo Alto Investors LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/palo-alto-investors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →